The district court in the underlying CareDX case remarked that the state of patent eligibility law is 'fraught, incoherent, unclear, inconsistent, and confusing, and indeterminate and often leading to arbitrary results.'
He said he was hopeful the Court might take up the CareDX petition because, unlike the American Axle case, where the Court denied certiorari last year, the patent at issue in CareDX stands to benefit human health.
[
add
]
[
|
|
...
]